Skip to content

Tracking fluid challenges non-invasively with thoracic impedance cardiography derived CO and pleth variability index

Tracking fluid challenges non-invasively with thoracic impedance cardiography derived CO and pleth variability index - TICO-PVI001

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48578
Enrollment
55
Registered
2018-04-24
Start date
2021-03-07
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

monitoring van bloedsomloop tijdens anesthesie fluid changes during surgery

Interventions

After induction of anaesthesia and once a steady state haemodynamic phase has been reached before incision, all patients will be administered 5ml kg-1 crystalloids i.v. in 5-10 minutes. The haemodyn

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Patients scheduled for elective non-cardiac surgery requiring invasive arterial blood pressure monitoring. * Patients older than 18. * ASA physical status I-III. * Informed and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: * Patients who refuse to participate. * Patients unable to consent (i.e. severe mental disorder, younger than 18). * Patients with pacemakers. * Patients with severe cardiac pathologies or hemodynamically unstable. * Patients with end-stage renal failure.

Design outcomes

Primary

MeasureTime frame
Raw COqCO data, which includes impedance variables, will be collected as a database and used for optimization and validation of the qCO algorithm Also, the absolute value of RPVI, as obtained by the Masimo Radical 7 monitor, and its fluid-induced change (*RPVI) will be assessed, in comparison to its clinical reference, SVV.

Secondary

MeasureTime frame
- Comparison of the prediction of fluid responsiveness by RPVI with both FloTrac/EV1000-derived SVV and traditional PVI. - Ability of RPVI to predict fluid responsiveness, defined as an increase in CO > 15%, and comparing it with the ability of SVV to predict fluid responsiveness. - Ability of SpHb to track changes in Hb concentration following fluid administration by comparing it to reference (satellite-lab) Hb values.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)